THERMO FISHER SCIENTIFIC INC. SEC Filing

Thermo Fisher Scientific (TMO) received a Form 144 notice for a proposed sale of up to 1,058 common shares through Fidelity Brokerage Services, with an aggregate market value of $622,135.54.

Accepted by SEC EDGAR 11/12/2025 - 05:06 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Thermo Fisher Scientific (TMO) received a Form 144 notice for a proposed sale of up to 1,058 common shares through Fidelity Brokerage Services, with an aggregate market value of $622,135.54. The shares are expected to be sold on the NYSE around 11/12/2025.

The securities were acquired via restricted stock vesting: 1,016 shares on 02/23/2022 and 42 shares on 08/25/2023. A related table shows 10,225 common shares were sold on 11/07/2025 for gross proceeds of $5,844,850.08. Shares outstanding were 375,708,059.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001676320
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	THERMO FISHER SCIENTIFIC INC.
SEC File Number	001-08002
Address of Issuer	168 THIRD AVENUE WALTHAM MASSACHUSETTS 02451
Phone	7816221000
Name of Person for Whose Account the Securities are To Be Sold	Britt Lisa P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1058	622135.54	375708059	11/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2022	Restricted Stock Vesting	Issuer			1016	02/23/2022	Compensation
Common	08/25/2023	Restricted Stock Vesting	Issuer			42	08/25/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lisa Britt 168 Third Avenue Waltham MA 02451	Common	11/07/2025	10225	5844850.08

144: Remarks and Signature

Remarks
Date of Notice	11/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jackson Harris, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Lisa Britt
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)